Technical Analysis for IMAB - I-Mab
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.66 | -4.60% | -0.08 |
IMAB closed down 4.6 percent on Friday, May 31, 2024, on 80 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
Expansion Breakdown | Bearish Swing Setup | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -4.60% | |
180 Bearish Setup | Bearish Swing Setup | -4.60% | |
Earnings Movers | Other | -4.60% | |
Outside Day | Range Expansion | -4.60% | |
Gapped Up | Strength | -4.60% |
Alert | Time |
---|---|
Fell Below 200 DMA | 1 day ago |
200 DMA Support | 1 day ago |
Down 3% | 1 day ago |
Fell Below Lower Bollinger Band | 1 day ago |
Down 2 % | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.38 |
52 Week Low | 1.16 |
Average Volume | 198,940 |
200-Day Moving Average | 1.69 |
50-Day Moving Average | 1.80 |
20-Day Moving Average | 1.77 |
10-Day Moving Average | 1.74 |
Average True Range | 0.06 |
RSI (14) | 31.97 |
ADX | 17.81 |
+DI | 18.51 |
-DI | 20.63 |
Chandelier Exit (Long, 3 ATRs) | 1.74 |
Chandelier Exit (Short, 3 ATRs) | 1.83 |
Upper Bollinger Bands | 1.85 |
Lower Bollinger Band | 1.69 |
Percent B (%b) | -0.21 |
BandWidth | 8.89 |
MACD Line | -0.02 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0084 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.80 | ||||
Resistance 3 (R3) | 1.81 | 1.78 | 1.77 | ||
Resistance 2 (R2) | 1.78 | 1.75 | 1.77 | 1.76 | |
Resistance 1 (R1) | 1.72 | 1.72 | 1.71 | 1.71 | 1.76 |
Pivot Point | 1.69 | 1.69 | 1.68 | 1.68 | 1.69 |
Support 1 (S1) | 1.63 | 1.66 | 1.62 | 1.62 | 1.56 |
Support 2 (S2) | 1.60 | 1.63 | 1.59 | 1.56 | |
Support 3 (S3) | 1.54 | 1.60 | 1.55 | ||
Support 4 (S4) | 1.53 |